Life Sciences Policy

1 article

A split image showing a sterile, advanced AI server room on one side and a wild, overgrown jungle with ominous shadows on the other, representing the conflict between technological and biological threats.

Biology, Not AI, Is Still the Bigger Organizational Risk — But 2026 Policy Treats Them as One Problem

In 2026, US policy began treating artificial intelligence and biological risks as a single, converging problem, establishing new regulations for dangerous gain-of-function research and AI monitoring in life sciences. While AI can accelerate biological threats, the article emphasizes that the physical accessibility of lab tools remains a more immediate organizational risk.

Jina Park·June 20, 2026